BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Synexus Celebrates Its 21st Birthday With a Forward Order Book of Over $100 Million


4/8/2013 11:46:58 AM

Monday 8th April 2013 -- Since its launch 21 years ago Synexus has grown from a small clinic adjoining founder Dr Smith’s surgery to the largest multinational organisation dedicated to the recruitment of patients and running of clinical trials at its 25 clinics across Europe and Africa.

Dr Christophe Berthoux, Chief Executive of Synexus said: “We had an excellent 2012 and expect 2013 to be even better. Our forward order book, which at this time exceeds $100 million, continues to grow. In the last two years we have undergone dramatic and positive change. To meet the growth in demand we have strengthened our management team and focussed on the therapy areas where we can add most value – cardiovascular, metabolic (diabetes and obesity), bone, respiratory and CNS (dementia and pain). This new strengthened structure means that we can now look forward to the next 21 years with an industry-leading management team as well as an infrastructure which better represents our global status.”

The reorganisation includes a new global management team, reporting to the executive management board, which is responsible for HR, IT and patient recruitment. This has already resulted in great improvement in patient recruitment with over 95% of trials achieving or exceeding their targets.

Synexus has also put in place a regional structure with managing directors being responsible for the management of their regions and the day-to-day running of their sites, including their performance and profitability.

All the regions report to COO Jane Restorick. Jane has an overriding responsibility for the quality of the data produced by each clinic and for patient care and to ensure these standards and adherence to best clinical practice is the same in every Synexus clinic anywhere in the world.

Christophe explains the success of the Synexus model “We’ve seen our model being adopted far more widely as our clients in pharma and CROs get to grips with the urgent need to address productivity issues in terms of bringing new drugs to market more quickly and less expensively.”

Synexus has shown that using its own Dedicated Research Centres speeds up clinical trials, makes them more cost-effective and delivers thousands of patients. In fact it has revolutionized the way late-stage clinical trials are carried out. Traditionally, individual doctors recruited four patients or less on an opportunistic basis which, with studies involving thousands of patients, is enormously expensive and wholly impractical.

Christophe sums up “Our excellent progress is directly related to putting in place a really professional structure which delivers quality data and patients. It has been a team effort which has been actively supported by our major shareholder Lyceum Capital. We are looking forward to a sustained period of growth.”



Read at BioSpace.com

Synexus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES